SCOPUS 정보 검색 플랫폼

Hepatology

Volumn 48, Issue 1, 2008, Pages 1-3

The need for better clinical trials

(1) Kamath, Patrick S a

a MAYO CLINIC (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LACTULOSE; RIFAXIMIN;

ASCITES; CHRONIC LIVER DISEASE; CLINICAL MEDICINE; CLINICAL PRACTICE; CLINICAL TRIAL; COST BENEFIT ANALYSIS; DRUG INDUSTRY; ECONOMIC ASPECT; EDITORIAL; ETHICS; FOLLOW UP; HEALTH CARE COST; HEPATIC ENCEPHALOPATHY; HEPATITIS C; HEPATORENAL SYNDROME; HOSPITALIZATION; LABORATORY TEST; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MARKETING; MEDICAL RESEARCH; MORTALITY; OUTCOME ASSESSMENT; PATIENT SAFETY; PRIORITY JOURNAL; PSYCHOMETRY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SAMPLE SIZE; SCIENCE; STATISTICAL SIGNIFICANCE; SURVIVAL; TREATMENT OUTCOME; VARICOSIS;

HEALTH SERVICES NEEDS AND DEMAND; HEPATIC ENCEPHALOPATHY; HEPATORENAL SYNDROME; HUMANS; LIVER CIRRHOSIS; LIVER DISEASES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN;

EID: 47149100487 PISSN: 02709139 EISSN: None Source Type: Journal
DOI: 10.1002/hep.22373 Document Type: Editorial

Times cited : (10)

References (7)

1
- 41449104685
- Drug-review deadlines and safety problems
- Carpenter D, Zucker EJ, Avoro J. Drug-review deadlines and safety problems. N Engl J Med 2008;358:1354-1361.
- (2008) N Engl J Med , vol.358 , pp. 1354-1361
- Carpenter, D.¹ Zucker, E.J.² Avoro, J.³

2
- 0033986821
- Sample size calculations for clinical trials: The impact of clinician beliefs
- Fayers P, Cuschieri A, Fielding J, Craven J, Uscinska B, Freedman LS. Sample size calculations for clinical trials: the impact of clinician beliefs. Br J Cancer 2000;82:213-219.
- (2000) Br J Cancer , vol.82 , pp. 213-219
- Fayers, P.¹ Cuschieri, A.² Fielding, J.³ Craven, J.⁴ Uscinska, B.⁵ Freedman, L.S.⁶

3
- 34247503838
- Problems with the use of composite end-points in cardiovascular trials: A systematic review of randomized control trials
- Ferrer-Gonzalez I, Busse J, Heels-Ansdell D, Montori VM, Akl EA, Bryant D, et al. Problems with the use of composite end-points in cardiovascular trials: a systematic review of randomized control trials. BMJ 2007;334:786-792.
- (2007) BMJ , vol.334 , pp. 786-792
- Ferrer-Gonzalez, I.¹ Busse, J.² Heels-Ansdell, D.³ Montori, V.M.⁴ Akl, E.A.⁵ Bryant, D.⁶

4
- 27644487803
- Randomized trials stopped early for benefit: A systematic review
- Montori V, Deveraux P, Adahikari NKJ, Burns KEA, Eggert CH, Briel M, et al. Randomized trials stopped early for benefit: a systematic review. JAMA 2005;294:2203-2209.
- (2005) JAMA , vol.294 , pp. 2203-2209
- Montori, V.¹ Deveraux, P.² Adahikari, N.K.J.³ Burns, K.E.A.⁴ Eggert, C.H.⁵ Briel, M.⁶

5
- 34347375380
- Ethical issues in stopping randomized trials early because of apparent benefit
- Mueller P, Montori V, Bassler D, Koenig BA, Guyatt GH. Ethical issues in stopping randomized trials early because of apparent benefit. Ann Intern Med 2007;146:878-881.
- (2007) Ann Intern Med , vol.146 , pp. 878-881
- Mueller, P.¹ Montori, V.² Bassler, D.³ Koenig, B.A.⁴ Guyatt, G.H.⁵

6
- 28144455912
- Portal Hypertension Collaborative Group. Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis
- Groszmann, RJ, Garcia-Tsao G, Bosch J, Grace ND, Burroughs AK, Planas R, et al.; Portal Hypertension Collaborative Group. Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis. N Engl J Med 2005;353:2254-2261.
- (2005) N Engl J Med , vol.353 , pp. 2254-2261
- Groszmann, R.J.¹ Garcia-Tsao, G.² Bosch, J.³ Grace, N.D.⁴ Burroughs, A.K.⁵ Planas, R.⁶

7
- 0028276374
- Statistical power, sample size, and their reporting in randomized controlled trials
- Moher D, Dulberg CS, Wells GA. Statistical power, sample size, and their reporting in randomized controlled trials. JAMA 1994;272:122-124.
- (1994) JAMA , vol.272 , pp. 122-124
- Moher, D.¹ Dulberg, C.S.² Wells, G.A.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.